Nexalin Technology (NXL) Other Non-Current Assets (2024)
Nexalin Technology (NXL) recorded quarterly Other Non-Current Assets of $864.0 in Q4 2024, down 98.41% quarter-over-quarter from $54414.0 in Q2 2024.
Nexalin Technology (NXL) Other Non-Current Assets (2024) Analysis & Trends
Nexalin Technology's Other Non-Current Assets history runs 1 years deep, the most recent figure standing at $864.0 for Q4 2024.
- In Q4 2024, Other Non-Current Assets changed N/A year-over-year to $864.0; the TTM figure through Dec 2024 stood at $864.0 (changed N/A YoY), while the FY2024 annual figure was $864.0, changed N/A from the prior year.
- Other Non-Current Assets was $864.0 for Q4 2024 at Nexalin Technology, down from $54414.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $54414.0 in Q2 2024 to a low of $864.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 828.89 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Nexalin Technology | 7.82 Mn | 5.11 Mn | 13,133.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 864.00 |
| Jun 30, 2024 | 54,414.00 |